UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Act of 1934
Date of Report (Date of earliest event reported): March 9, 2016
Omega Protein Corporation
(Exact name of registrant as specified in its charter)
Nevada
(State or other jurisdiction
of incorporation) | 001-14003
(Commission
File Number) | 76-0562134
(I.R.S. Employer
Identification No.) |
2105 City West Blvd., Suite 500 Houston, Texas
(Address of principal executive offices) | 77042
(Zip Code) |
(713) 623-0060
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CRF 240.133-4(c))
Item 2.02. Results of Operations and Financial Condition
On March 9, 2016, Omega Protein Corporation (the “Company”) issued a press release reporting the Company’s earnings for the year and quarter ended December 31, 2015. For additional information regarding the Company’s full year and fourth quarter earnings, please refer to the Company’s press release attached to this report as Exhibit 99.1 and incorporated herein by reference.
Item 9.01 Financial Statements, Pro Forma Financial Information and Exhibits
| (a) | Financial Statements of business acquired. |
| | | |
| | | None. |
| (b) | Pro Forma Financial Information. |
| | | |
| | | None. |
| (c) | Shell Company Transactions. |
| | | |
| | | None. |
| 99.1 | Text of Press Release dated March 9, 2016 titled “Omega ProteinAnnounces Fourth Quarter and Full Year 2015 Financial Results.” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | Omega Protein Corporation | |
| | | |
| | | |
| Dated: March 9, 2016 | | /s/John D. Held | |
| | | John D. Held | |
| | | Executive Vice President and General Counsel | |
